NYSE: JNJ
Johnson & Johnson insiders
The officers, directors and 10% owners of Johnson & Johnson who hold the most stock, valued at the live JNJ price.
$267.14
JNJ today −$5.6M (−2.04%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 19
- Their JNJ stock
- $559M
- Market value
- $664.0B
- Held by ranked insiders
- <0.1%
Insiders by value of JNJ holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Alex Gorsky | Director | 768,336 | $205M | <0.1% | 860th |
| 2 | Joaquin Duato | CEO and Chairman of the Board | 308,825 | $82.5M | <0.1% | 1738th |
| 3 | Jennifer Taubert | EVP, WWC. Innovative Medicine | 194,451 | $51.9M | <0.1% | 2469th |
| 4 | Michael H. Ullmann | Exec VP, General Counsel | 160,555 | $42.9M | <0.1% | 2839th |
| 5 | Kathryn E. Wengel | EVP, Chief TO and Risk Officer | 114,659 | $30.6M | <0.1% | 3578th |
| 6 | Peter Fasolo | Exec VP, Chief HR Officer | 112,076 | $29.9M | <0.1% | 3785th |
| 7 | Joseph J. Wolk | Exec VP, CFO | 85,008 | $22.7M | <0.1% | 4701st |
| 8 | Thibaut Mongon | Exec VP, WW Chair, Cons Health | 65,915 | $17.6M | <0.1% | 5709th |
| 9 | Ashley McEvoy | EVP, WW Chair, MedTech | 55,144 | $14.7M | <0.1% | 5352nd |
| 10 | Mathai Mammen | EVP, Pharm, R&D | 41,934 | $11.2M | <0.1% | 4895th |
| 11 | William Hait | See Remarks | 38,647 | $10.3M | <0.1% | 8577th |
| 12 | Timothy Schmid | EVP, WW Chair, MedTech | 26,251 | $7.0M | <0.1% | 11381st |
| 13 | James Swanson | EVP, CIO | 25,698 | $6.9M | <0.1% | 11576th |
| 14 | John C. Reed | EVP, Innovative Medicine, R&D | 24,911 | $6.7M | <0.1% | 11510th |
| 15 | Robert J. Decker | VP Corporate Controller | 24,462 | $6.5M | <0.1% | 11981st |
| 16 | Vanessa Broadhurst | EVP, Global Corp Affairs | 23,003 | $6.1M | <0.1% | 12096th |
| 17 | Kristen Mulholland | EVP, Chief HR Officer | 19,830 | $5.3M | <0.1% | 13881st |
| 18 | John G. Morikis | Director | 1,849 | $494K | <0.1% | 982nd |
| 19 | Darius Adamczyk | Director | 1,063 | $284K | <0.1% | 2492nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Johnson & Johnson; see each profile for the filing.